Bespoke Extracts (BSPK) Change in Inventory (2017 - 2025)
Bespoke Extracts (BSPK) reported Change in Inventory of $21941.0 for Q3 2025, up 84.29% on a YoY basis from $11906.0 in Q3 2024, and up 678.88% sequentially from $2817.0 in Q2 2025.
Bespoke Extracts (BSPK) Change in Inventory (2017 - 2025) Analysis & Trends
Bespoke Extracts (BSPK) has 9 years of Change in Inventory data on file, last reported at $21941.0 in Q3 2025.
- For the quarter ending Q3 2025, Change in Inventory rose 84.29% year-over-year to $21941.0; the trailing twelve-month figure through Sep 2025 stood at $19435.0 (up 4.1% YoY), and the FY2024 full-year result was $16726.0, down 70.23% from the prior year.
- Change in Inventory rose to $21941.0 in Q3 2025, from $2817.0 in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of $53403.0 in Q1 2023 to a low of -$16807.0 in Q3 2023.
- A 5-year average of $14455.6 and a median of $9142.0 in 2024 frame the typical range for Change in Inventory.
- Across the five-year window, Change in Inventory jumped 15143.1% in 2023 and tumbled 122.33% in 2024, its largest moves.
- Tracing BSPK's Change in Inventory over 5 years: stood at -$1329.0 in 2021, then soared by 73.29% to -$355.0 in 2022, then sank by 2648.45% to -$9757.0 in 2023, then retreated by 19.92% to -$11701.0 in 2024, then jumped by 287.51% to $21941.0 in 2025.
- Business Quant data shows BSPK's Change in Inventory at $21941.0 in Q3 2025, $2817.0 in Q2 2025, and $6378.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -93.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 114.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 119.24 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 40.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 123.00 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -4.30 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Bespoke Extracts | 1.12 Mn | 1.11 Mn | 234,175.00 | 21,941.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 21,941.00 |
| Sep 30, 2025 | 21,941.00 |
| Jun 30, 2025 | 2,817.00 |
| Jun 30, 2025 | 2,817.00 |
| Mar 31, 2025 | 6,378.00 |
| Mar 31, 2025 | 6,378.00 |
| Dec 31, 2024 | -11,701.00 |
| Dec 31, 2024 | -11,701.00 |
| Sep 30, 2024 | 11,906.00 |
| Sep 30, 2024 | 11,906.00 |
| Jun 30, 2024 | -6,555.00 |
| Jun 30, 2024 | -6,555.00 |
| Mar 31, 2024 | 23,076.00 |
| Mar 31, 2024 | 23,076.00 |
| Dec 31, 2023 | -9,757.00 |
| Dec 31, 2023 | -9,757.00 |
| Sep 30, 2023 | -16,807.00 |
| Sep 30, 2023 | -16,807.00 |
| Jun 30, 2023 | 29,354.00 |
| Jun 30, 2023 | 29,354.00 |